3567-82-6

Usage

Uses

Used in Pharmaceutical Industry:
alpha-(aminomethyl)-3,4-dichlorobenzyl alcohol is used as an antifungal and antibacterial agent for its effective antimicrobial properties, playing a crucial role in the treatment and prevention of various infections and diseases.
Used in Personal Care Products:
In the personal care industry, alpha-(aminomethyl)-3,4-dichlorobenzyl alcohol is used as an active ingredient in mouthwashes, skin cleansers, and topical antiseptics, where it helps maintain hygiene and prevent microbial growth.
Used in Research and Development:
alpha-(aminomethyl)-3,4-dichlorobenzyl alcohol is also utilized in research for its potential as a therapeutic agent, with ongoing studies exploring its efficacy in treating a broader range of infections and diseases, thereby expanding its applications in the medical field.

InChI:InChI=1/C8H9Cl2NO/c9-6-2-1-5(3-7(6)10)8(12)4-11/h1-3,8,12H,4,11H2

Upstream product

• 958452-69-2 (3,4-dichloro-phenyl)-glyoxal-2-oxime 
• 2642-63-9 3',4'-dichloroacetophenone 
• 42981-08-8 2,3',4'-trichloroacetophenone 
• 2632-10-2 2-bromo-1-(3,4-dichlorophenyl)ethanone 
• 41995-19-1 2-amino-1-(3,4-dichloro-phenyl)-ethanone; hydrochloride 
• 95-50-1 1,2-dichloro-benzene 
• 6287-38-3 3,4-dichlorobenzaldehyde 
• 53065-95-5 2-chloro-1-(3,4-dichlorophenyl)ethan-1-ol 
• 380650-10-2 2-amino-1-(3,4-dichloro-phenyl)-ethanone 

Downstream Products

• 68287-28-5 1-(3,4-dichloro-phenyl)-2-(1,1-dioxo-1H-1λ⁶-benzo[d]isothiazol-3-ylamino)-ethanol 
• 1254942-00-1 5-([1,2,4]triazolo[1,5-α]pyridin-6-yl)-4-(3,4-dichlorophenyl)-1,2,3,4-tetrahydroisoquinoline 
• 1254941-99-5 7-([1,2,4]triazolo[1,5-a]pyridin-6-yl)-4-(3,4-dichlorophenyl)-1,2,3,4-tetrahydroisoquinoline 
• 1254941-84-8 2-(3-([1,2,4]triazolo[1,5-a;]pyridin-6-yl)benzylamino)-1-(3,4-dichlorophenyl)ethanol 
• 875305-43-4 [rac]-(4-tert-butyl-benzyl)-[2-(3,4-dichloro-phenyl)-2-hydroxy-ethyl]-amine 

Relevant academic research and scientific papers

ARYL, HETEROARYL, AND HETEROCYCLE SUBSTITUTED TETRAHYDROISOQUINOLINES AND USE THEREOF

Novel aryl, heteroaryl, and non-aromatic heterocyle substituted tetrahydroisoquinolines are described in the present invention. These compounds are used in the treatment of various neurological and physiological disorders. Methods of making these compounds are also described in the present invention.

ARYL-HYDROXYETHYLAMINO-PYRIMIDINES AND TRIAZINES AS MODULATORS OF FATTY ACID AMIDE HYDROLASE

Certain aryl-hydroxyethylamino-pyrimidine and triazine compounds are described, which are useful as FAAH inhibitors. Such compounds may be used in pharmaceutical compositions and methods for the treatment of disease states, disorders, and conditions mediated by fatty acid amide hydrolase (FAAH) activity, such as anxiety, pain, inflammation, sleep disorders, eating disorders, energy metabolism disorders, and movement disorders (e.g., multiple sclerosis). Methods of synthesizing such compounds are also disclosed.

Novel 1H-(benzimidazol-2-yl)-1H-pyridin-2-one inhibitors of insulin-like growth factor I (IGF-1R) kinase

A novel class of 1H-(benzimidazol-2-yl)-1H-pyridin-2-one inhibitors of insulin-like growth factor I (IGF-1R) kinase is described. This report discusses the SAR of 4-(2-hydroxy-2-phenylethylamino)-substituted pyridones with improved IGF-1R potency.

Indole, indazole and indoline derivatives as CETP inhibitors

The present invention relates to compounds of formula (I): wherein —X—Y—, R1 to R11 and n are as defined in the description and claims, and pharmaceutically acceptable salts thereof. The compounds are useful for the treatment and/or prevention of diseases which are mediated by CETP inhibitors.